Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1998 Mar;152(3):749–757.

Binding of RANTES, MCP-1, MCP-3, and MIP-1alpha to cells in human skin.

E Hub 1, A Rot 1
PMCID: PMC1858396  PMID: 9502417

Abstract

Based on their ability to induce leukocyte chemotaxis and adhesion to endothelial cells (ECs), chemokines have been implicated in driving inflammatory leukocyte emigration. Recently, it was suggested that chemokines can accomplish their pro-emigratory role more effectively while being bound to the luminal surface of the ECs. Previously, such binding was demonstrated in situ in human skin for the prototype alpha-chemokine interleukin (IL)-8. Here we used an in situ binding assay to investigate the binding characteristics of several beta-chemokines in intact human skin. RANTES, MCP-1, and MCP-3 bound, similar to IL-8, in a specific saturable manner to the ECs of venules and small veins but not arteries or capillaries. RANTES inhibited MCP-1 and MCP-3 binding and vice versa, indicating that the EC binding sites are shared among these beta-chemokines; moreover, IL-8 and RANTES cross-competed for each other's binding, suggesting that the same chemokine binding sites are used by members of alpha- and beta-chemokine subfamilies. Conversely, MIP-1alpha did not bind to the ECs and did not compete for binding of RANTES. Analogous to IL-8, all of the tested beta-chemokines bound to the resident dermal cells. As a novel aspect of chemokine interaction with cells in normal skin, we observed specific, saturable binding of RANTES, MCP-1, and MCP-3 but not MIP-1alpha or IL-8 to the ECs of dermal afferent lymphatic vessels. RANTES, MCP-1, and MCP-3 also cross-competed for each other's binding to lymphatics, suggesting a common binding site with a novel chemokine binding profile. We suggest that the chemokine binding to the ECs of lymphatics may be involved in the process of leukocyte entry into the afferent lymphatic vessels.

Full text

PDF
749

Images in this article

751Figure 1
on p.751
753Figure 2
on p.753
754Figure 3
on p.754
754Figure 4
on p.754
755Figure 5
on p.755
756Figure 6
on p.756

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baggiolini M., Dewald B., Moser B. Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines. Adv Immunol. 1994;55:97–179. [PubMed] [Google Scholar]
  2. Butcher E. C., Picker L. J. Lymphocyte homing and homeostasis. Science. 1996 Apr 5;272(5258):60–66. doi: 10.1126/science.272.5258.60. [DOI] [PubMed] [Google Scholar]
  3. Charo I. F., Myers S. J., Herman A., Franci C., Connolly A. J., Coughlin S. R. Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2752–2756. doi: 10.1073/pnas.91.7.2752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Combadiere C., Ahuja S. K., Tiffany H. L., Murphy P. M. Cloning and functional expression of CC CKR5, a human monocyte CC chemokine receptor selective for MIP-1(alpha), MIP-1(beta), and RANTES. J Leukoc Biol. 1996 Jul;60(1):147–152. doi: 10.1002/jlb.60.1.147. [DOI] [PubMed] [Google Scholar]
  5. Graham G. J., MacKenzie J., Lowe S., Tsang M. L., Weatherbee J. A., Issacson A., Medicherla J., Fang F., Wilkinson P. C., Pragnell I. B. Aggregation of the chemokine MIP-1 alpha is a dynamic and reversible phenomenon. Biochemical and biological analyses. J Biol Chem. 1994 Feb 18;269(7):4974–4978. [PubMed] [Google Scholar]
  6. Gretz J. E., Kaldjian E. P., Anderson A. O., Shaw S. Sophisticated strategies for information encounter in the lymph node: the reticular network as a conduit of soluble information and a highway for cell traffic. J Immunol. 1996 Jul 15;157(2):495–499. [PubMed] [Google Scholar]
  7. Hadley T. J., Lu Z. H., Wasniowska K., Martin A. W., Peiper S. C., Hesselgesser J., Horuk R. Postcapillary venule endothelial cells in kidney express a multispecific chemokine receptor that is structurally and functionally identical to the erythroid isoform, which is the Duffy blood group antigen. J Clin Invest. 1994 Sep;94(3):985–991. doi: 10.1172/JCI117465. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kemény L., Ruzicka T., Dobozy A., Michel G. Role of interleukin-8 receptor in skin. Int Arch Allergy Immunol. 1994 Aug;104(4):317–322. doi: 10.1159/000236686. [DOI] [PubMed] [Google Scholar]
  9. Lukas M., Stössel H., Hefel L., Imamura S., Fritsch P., Sepp N. T., Schuler G., Romani N. Human cutaneous dendritic cells migrate through dermal lymphatic vessels in a skin organ culture model. J Invest Dermatol. 1996 Jun;106(6):1293–1299. doi: 10.1111/1523-1747.ep12349010. [DOI] [PubMed] [Google Scholar]
  10. Middleton J., Neil S., Wintle J., Clark-Lewis I., Moore H., Lam C., Auer M., Hub E., Rot A. Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell. 1997 Oct 31;91(3):385–395. doi: 10.1016/s0092-8674(00)80422-5. [DOI] [PubMed] [Google Scholar]
  11. Nanney L. B., Mueller S. G., Bueno R., Peiper S. C., Richmond A. Distributions of melanoma growth stimulatory activity of growth-regulated gene and the interleukin-8 receptor B in human wound repair. Am J Pathol. 1995 Nov;147(5):1248–1260. [PMC free article] [PubMed] [Google Scholar]
  12. Neote K., Darbonne W., Ogez J., Horuk R., Schall T. J. Identification of a promiscuous inflammatory peptide receptor on the surface of red blood cells. J Biol Chem. 1993 Jun 15;268(17):12247–12249. [PubMed] [Google Scholar]
  13. Neote K., DiGregorio D., Mak J. Y., Horuk R., Schall T. J. Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor. Cell. 1993 Feb 12;72(3):415–425. doi: 10.1016/0092-8674(93)90118-a. [DOI] [PubMed] [Google Scholar]
  14. Peiper S. C., Wang Z. X., Neote K., Martin A. W., Showell H. J., Conklyn M. J., Ogborne K., Hadley T. J., Lu Z. H., Hesselgesser J. The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor. J Exp Med. 1995 Apr 1;181(4):1311–1317. doi: 10.1084/jem.181.4.1311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Rot A. Binding of neutrophil attractant/activation protein-1 (interleukin 8) to resident dermal cells. Cytokine. 1992 Sep;4(5):347–352. doi: 10.1016/1043-4666(92)90077-5. [DOI] [PubMed] [Google Scholar]
  16. Rot A. Endothelial cell binding of NAP-1/IL-8: role in neutrophil emigration. Immunol Today. 1992 Aug;13(8):291–294. doi: 10.1016/0167-5699(92)90039-A. [DOI] [PubMed] [Google Scholar]
  17. Schall T. J., Bacon K. B. Chemokines, leukocyte trafficking, and inflammation. Curr Opin Immunol. 1994 Dec;6(6):865–873. doi: 10.1016/0952-7915(94)90006-x. [DOI] [PubMed] [Google Scholar]
  18. Springer T. A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 1994 Jan 28;76(2):301–314. doi: 10.1016/0092-8674(94)90337-9. [DOI] [PubMed] [Google Scholar]
  19. Strieter R. M., Standiford T. J., Huffnagle G. B., Colletti L. M., Lukacs N. W., Kunkel S. L. "The good, the bad, and the ugly." The role of chemokines in models of human disease. J Immunol. 1996 May 15;156(10):3583–3586. [PubMed] [Google Scholar]
  20. Szabo M. C., Soo K. S., Zlotnik A., Schall T. J. Chemokine class differences in binding to the Duffy antigen-erythrocyte chemokine receptor. J Biol Chem. 1995 Oct 27;270(43):25348–25351. doi: 10.1074/jbc.270.43.25348. [DOI] [PubMed] [Google Scholar]
  21. Tanaka Y., Adams D. H., Hubscher S., Hirano H., Siebenlist U., Shaw S. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1 beta. Nature. 1993 Jan 7;361(6407):79–82. doi: 10.1038/361079a0. [DOI] [PubMed] [Google Scholar]
  22. Tanaka Y., Adams D. H., Shaw S. Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes. Immunol Today. 1993 Mar;14(3):111–115. doi: 10.1016/0167-5699(93)90209-4. [DOI] [PubMed] [Google Scholar]
  23. Webb L. M., Ehrengruber M. U., Clark-Lewis I., Baggiolini M., Rot A. Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8. Proc Natl Acad Sci U S A. 1993 Aug 1;90(15):7158–7162. doi: 10.1073/pnas.90.15.7158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Wiedermann C. J., Kowald E., Reinisch N., Kaehler C. M., von Luettichau I., Pattison J. M., Huie P., Sibley R. K., Nelson P. J., Krensky A. M. Monocyte haptotaxis induced by the RANTES chemokine. Curr Biol. 1993 Nov 1;3(11):735–739. doi: 10.1016/0960-9822(93)90020-o. [DOI] [PubMed] [Google Scholar]
  25. Witt D. P., Lander A. D. Differential binding of chemokines to glycosaminoglycan subpopulations. Curr Biol. 1994 May 1;4(5):394–400. doi: 10.1016/s0960-9822(00)00088-9. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES